Legal & General Group PLC Eloxx Pharmaceuticals, Inc. Transaction History

Legal & General Group PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$1.35 - $3.36 $4,094 - $10,190	-3,033 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$2.53 - $3.4 $2,636 - $3,542	-1,042 Reduced 25.57%	3,033 $8,000
Q1 2020 May 14, 2020	SELL	$1.96 - $7.96 $2,630 - $10,682	-1,342 Reduced 24.77%	4,075 $8,000
Q4 2019 Feb 13, 2020	BUY	$3.19 - $7.56 $5,572 - $13,207	1,747 Added 47.6%	5,417 $40,000
Q4 2018 Feb 15, 2019	BUY	$10.43 - $17.39 $4,849 - $8,086	465 Added 14.51%	3,670 $44,000
Q2 2018 Aug 10, 2018	BUY	$8.75 - $23.27 $28,043 - $74,580	3,205 New	3,205 $55,000

Ticker ELOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,656,200
Description
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis p...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.